Cutaneous manifestations of cystic fibrosis

被引:3
作者
Smith, Aaron D. [1 ]
Schwartzman, Gabrielle [2 ]
Lyons, Catherine E. [1 ]
Flowers, Hal [2 ]
Albon, Dana [3 ]
Greer, Kenneth [2 ]
Lonabaugh, Kevin [3 ]
Zlotoff, Barrett J. [2 ]
机构
[1] Univ Virginia, Sch Med, Charlottesville, VA USA
[2] Univ Virginia, Dept Dermatol, Charlottesville, VA USA
[3] Univ Virginia, Dept Pulmonol & Crit Care Med, Charlottesville, VA USA
关键词
adverse events; transient reactive papulotranslucent acrokeratoderma of the palm; CFTR; Cystic fibrosis; nutrient deficiency dermatitis; vasculitis; FATTY-ACID-METABOLISM; TEZACAFTOR-IVACAFTOR; IMMUNE-COMPLEXES; ALLERGY; PROTEIN; PATHOGENESIS; DERMATITIS; INFANTS; CFTR;
D O I
10.1016/j.jaad.2024.04.052
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Cystic fibrosis (CF) is caused by a mutation in the Cystic fibrosis transmembrane conductance regulator (CFTR) gene, and features recurrent sinus and pulmonary infections, steatorrhea, and malnutrition. CF is associated with diverse cutaneous manifestations, including transient reactive papulotranslucent acrokeratoderma of the palms, nutrient deficiency dermatoses, and vasculitis. Rarely these are presenting symptoms of CF, prior to pulmonary or gastrointestinal sequelae. Cutaneous drug eruptions are also highly common in patients with CF (PwCF) given frequent antibiotic exposure. Finally, CFTR modulating therapy, which has revolutionized CF management, is associated with cutaneous side effects ranging from acute urticaria to toxic epidermal necrolysis. Recognition of dermatologic clinical manifestations of CF is important to appropriately care for PwCF. Dermatologists may play a significant role in the diagnosis and management of CF and associated skin complications.
引用
收藏
页码:490 / 498
页数:9
相关论文
共 95 条
  • [1] PERSISTENT MORBIDITY AND MORTALITY OF PROTEIN CALORIE MALNUTRITION IN YOUNG INFANTS WITH CF
    ABMAN, SH
    ACCURSO, FJ
    BOWMAN, CM
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1986, 5 (03) : 393 - 396
  • [2] Effect of VX-770 in Persons with Cystic Fibrosis and the G551D-CFTR Mutation
    Accurso, Frank J.
    Rowe, Steven M.
    Clancy, J. P.
    Boyle, Michael P.
    Dunitz, Jordan M.
    Durie, Peter R.
    Sagel, Scott D.
    Hornick, Douglas B.
    Konstan, Michael W.
    Donaldson, Scott H.
    Moss, Richard B.
    Pilewski, Joseph M.
    Rubenstein, Ronald C.
    Uluer, Ahmet Z.
    Aitken, Moira L.
    Freedman, Steven D.
    Rose, Lynn M.
    Mayer-Hamblett, Nicole
    Dong, Qunming
    Zha, Jiuhong
    Stone, Anne J.
    Olson, Eric R.
    Ordonez, Claudia L.
    Campbell, Preston W.
    Ashlock, Melissa A.
    Ramsey, Bonnie W.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (21) : 1991 - 2003
  • [3] Vancomycin Infusion Reaction - Moving beyond "Red Man Syndrome"
    Alvarez-Arango, Santiago
    Ogunwole, S. Michelle
    Sequist, Thomas D.
    Burk, Caitlin M.
    Blumenthal, Kimberly G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (14) : 1283 - 1286
  • [4] Ashkani-Esfahani Soheil, 2014, Adv Biomed Res, V3, P204, DOI 10.4103/2277-9175.142314
  • [5] Cutaneous allergic drug reactions: update on pathophysiology, diagnostic procedures and differential diagnosic
    Balakirski, Galina
    Merk, Hans F.
    [J]. CUTANEOUS AND OCULAR TOXICOLOGY, 2017, 36 (04) : 307 - 316
  • [6] Cutaneous manifestations of cystic fibrosis
    Bernstein, Megan L.
    McCusker, Meagen M.
    Grant-Kels, Jane M.
    [J]. PEDIATRIC DERMATOLOGY, 2008, 25 (02) : 150 - 157
  • [7] Sulfonamide allergy and cross-reactivity
    Brackett, Carolyn C.
    [J]. CURRENT ALLERGY AND ASTHMA REPORTS, 2007, 7 (01) : 41 - 48
  • [8] Serum sickness-like reaction following initiation of elexacaftor/tezacaftor/ivacaftor therapy
    Brennan, Steven
    Marmor, Itay
    Schafer, Christine
    Ko, James
    Torres Garcia, Jose A.
    Rosman, Ilana S.
    Coughlin, Carrie
    Coverstone, Andrea
    White, Andrew J.
    [J]. PEDIATRIC PULMONOLOGY, 2020, 55 (11) : 2846 - 2847
  • [9] Cephalosporins: A Focus on Side Chains and β-Lactam Cross-Reactivity
    Chaudhry, Saira B.
    Veve, Michael P.
    Wagner, Jamie L.
    [J]. PHARMACY, 2019, 7 (03)
  • [10] Aminoglycoside Allergic Reactions
    Childs-Kean, Lindsey M.
    Shaeer, Kristy M.
    Gupta, Sheeba Varghese
    Cho, Jonathan C.
    [J]. PHARMACY, 2019, 7 (03)